SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-032977
Filing Date
2020-07-22
Accepted
2020-07-22 07:15:25
Documents
13
Period of Report
2020-07-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-8k_20200721.htm   iXBRL 8-K 40405
2 EX-99.1 mygn-ex991_43.htm EX-99.1 18086
  Complete submission text file 0001564590-20-032977.txt   191296

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mygn-20200721.xsd EX-101.SCH 5768
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20200721_lab.xml EX-101.LAB 18734
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20200721_pre.xml EX-101.PRE 11169
6 EXTRACTED XBRL INSTANCE DOCUMENT mygn-8k_20200721_htm.xml XML 3414
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 201040258
SIC: 2835 In Vitro & In Vivo Diagnostic Substances